Science | Nature | Cell | View More
Serial Products
Information
ChemFaces have 10 compounds are similar structure. Huperzine C (CAS#163089-71-2); Huperzine A (CAS#120786-18-7); Huperzine B (CAS#103548-82-9); N-Demethyl-alpha-obscurine (CAS#34399-44-5); Alpha-Obscurine (CAS#596-55-4); Lucidioline (CAS#22594-91-8); 6alpha-Hydroxylycopodine (CAS#21061-92-7); Dendrobine (CAS#2115-91-5); 3-Chloro-4-hydroxypiperidin-2-one (CAS#174204-83-2); 5,6-Dihydropyridin-2(1H)-one (CAS#6052-73-9).
Those compounds are series compounds, which having the similar structure but only some different in the individual atoms, functional groups and substructures. Maybe they also have the different physicochemical property, bioactivity and pharmacological property. In the drug design and reserach, they play an important role of improving the success rate of drug screening, researching of drug toxicity and acquiring of other data.
Products
Product Name Huperzine C Huperzine C
Catalog No.CFN90345
CAS Number163089-71-2
Purity>=98%
M. FC15H18N2O
M. W242.32
Price Inquiry
Product Name Huperzine A Huperzine A
Catalog No.CFN99959
CAS Number120786-18-7
Purity>=98%
M. FC15H18N2O
M. W242.32
Price$100 / 20mg
Product Name Huperzine B Huperzine B
Catalog No.CFN99960
CAS Number103548-82-9
Purity>=98%
M. FC16H20N2O
M. W256.35
Price$288 / 20mg
Product Name N-Demethyl-alpha-obscurine N-Demethyl-alpha-obscurine
Catalog No.CFN89068
CAS Number34399-44-5
Purity>=98%
M. FC16H24N2O
M. W260.38
Price Inquiry
Product Name Alpha-Obscurine Alpha-Obscurine
Catalog No.CFN96411
CAS Number596-55-4
Purity>=98%
M. FC17H26N2O
M. W274.4
Price$318 / 5mg
Product Name Lucidioline Lucidioline
Catalog No.CFN89120
CAS Number22594-91-8
Purity>=98%
M. FC16H25NO2
M. W263.38
Price Inquiry
Product Name 6alpha-Hydroxylycopodine 6alpha-Hydroxylycopodine
Catalog No.CFN89109
CAS Number21061-92-7
Purity>=98%
M. FC16H25NO2
M. W263.38
Price Inquiry
Product Name Dendrobine Dendrobine
Catalog No.CFN99133
CAS Number2115-91-5
Purity>=98%
M. FC16H25NO2
M. W263.38
Price$188 / 20mg
Product Name 3-Chloro-4-hydroxypiperidin-2-one 3-Chloro-4-hydroxypiperidin-2-one
Catalog No.CFN96086
CAS Number174204-83-2
Purity>=98%
M. FC5H8ClNO2
M. W149.6
Price Inquiry
Product Name 5,6-Dihydropyridin-2(1H)-one 5,6-Dihydropyridin-2(1H)-one
Catalog No.CFN96112
CAS Number6052-73-9
Purity>=98%
M. FC5H7NO
M. W97.1
Price Inquiry
Screening Libraries
Anticancer Compound Library

A unique collection of 823 Anticancer Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Anti-inflammatory Compound Library

A unique collection of 898 Anti-inflammatory Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Antioxidants Compound Library

A unique collection of 801 Antioxidants Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Inhibitors Compound Library

A unique collection of 740 Inhibitors Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Neuroprotection Compound Library

A unique collection of 348 Neuroprotection Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Antibacterial Compound Library

A unique collection of 471 Antibacterial Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Hepatoprotective Compound Library

A unique collection of 251 Hepatoprotective Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Antiviral Compound Library

A unique collection of 276 Antiviral Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Cytotoxic Compound Library

A unique collection of 431 Cytotoxic Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research
Antifungal Compound Library

A unique collection of 236 Antifungal Compound Library for high throughput screening (HTS), high content screening (HCS) and New drug research